COVID-19 morbidity and mortality are increased in patients with diabetes and kidney
disease via unknown mechanisms. SARS-CoV-2 uses angiotensin-converting enzyme 2 …

Corona virus disease 2019 (COVID-19) imposes a serious public health pandemic affecting
the whole world, as it is spreading exponentially. Besides its high infectivity, SARS-CoV-2 …

It is not well understood why diabetic individuals are more prone to develop severe COVID-
19. To this, we here established a human kidney organoid model promoting early hallmarks …

COVID-19-associated acute kidney injury (COVID-AKI) is a common complication of SARS-
CoV-2 infection in hospitalized patients. The susceptibility of human kidneys to direct SARS …

The present review describes COVID-19 severity in diabetes and diabetic kidney disease.
We discuss the crucial effect of COVID-19-associated cytokine storm and linked injuries and …

The new disease produced by severe acute respiratory syndrome-coronavirus 2 (SARS-
CoV-2) represents a major pandemic event nowadays. Since its origin in China in …

Background A novel coronavirus called SARS‐Cov‐2, which shared 82% similarity of
genome sequence with SARS‐CoV, was found in Wuhan in late December of 2019, causing …

Background Although coronavirus disease 2019 (COVID-19) causes significan t morbidity,
mainly from pulmonary involvement, extrapulmonary symptoms are also major componen ts …

Aims Angiotensin-converting enzyme 2 (ACE2) is the cellular entry point for severe acute
respiratory syndrome coronavirus (SARS-CoV-2)—the cause of coronavirus disease 2019 …

Six recent publications have provided evidence compatible with the conclusion that severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can directly infect the kidney …